Skip to content

Chronic Effects of Two Aerobic-training Models Performed in Water and on Dry Land in Patients With Type 2 Diabetes Mellitus (T2DM).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01956357
Enrollment
35
Registered
2013-10-08
Start date
2012-08-31
Completion date
Unknown
Last updated
2014-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

aquatic exercises;, deep water running;, diabetes;, blood glucose;, inflammation.

Brief summary

The aim of this study was to analyse the acute and chronic effects of two aerobic-training models performed in water and on dry land on cardiorespiratory, functional, metabolic, hormonal and quality-of-life parameters in patients with type 2 diabetes mellitus (T2DM).

Interventions

Sponsors

Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The clinical diagnosis of type 2 diabetes mellitus. Not be performing regular and systematic physical exercise for at least three months.

Exclusion criteria

Uncontrolled hypertension. Autonomic neuropathy. Severe peripheral neuropathy. Proliferative diabetic retinopathy. Severe nonproliferative diabetic retinopathy. Uncompensated heart failure. Peripheral amputations. Chronic renal failure (GFR by MDRD \<30). Muscle or joint injury that prevents physical exercises.

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobinBaseline and after 12 weeks of intervention

Secondary

MeasureTime frame
Low density lipoprotein.Baseline and after 12 weeks of intervention.
superoxide dismutase (SOD)Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Catalase (CAT)Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Glutathione peroxidase (GPX)Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Total radical-trapping antioxidant potential (TRAP)Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Interleukin 1βBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Interleukin 10Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Leukocyte DNA MethylationBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
PurinesBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Interleukin 6Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Global Histone Deacetylases activityBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
8-isoprostaneBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Content of reative species (DCF)Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Fasting plasma glucose.Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Postprandial glucoseBaseline and after 12 weeks of intervention.
Fasting insulin.Baseline and after 12 weeks of intervention.
Insulin resistance (HOMA-IR).Baseline and after 12 weeks of intervention.
Total cholesterol.Baseline and after 12 weeks of intervention.
High density lipoprotein.Baseline and after 12 weeks of intervention.
Triglycerides.Baseline and after 12 weeks of intervention.
Plasma renin activity.Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Angiotensin II.Before and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
C-reactive protein ultrasensitive.Baseline and after 12 weeks of intervention.
Water-soluble Fluorescent SubstancesBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Oxidation of tyrosine residuesBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.
Oxidation of tryptophanBefore and after a session of 45 minutes of exercise; baseline and after 12 weeks of intervention.

Other

MeasureTime frame
Oxygen uptake at ventilatory threshold.Baseline and after 12 weeks of intervention.
Percentage of oxygen consumption at ventilatory threshold.Baseline and after 12 weeks of intervention.
Systolic blood pressure.Baseline and after 12 weeks of intervention.
Diastolic blood pressureBaseline and after 12 weeks of intervention.
Resting heart rate.Baseline and after 12 weeks of intervention.
Quality of life.Baseline and after 12 weeks of intervention.
Depressive symptoms.Baseline and after 12 weeks of intervention.
Sleep quality.Baseline and after 12 weeks of intervention.
Peak oxygen consumption.Baseline and after 12 weeks of intervention.
Timed up and go in habitual speed and maximal speed.Baseline and after 12 weeks of intervention.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026